News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

Molecure has submitted a new application for approval to conduct a Phase II clinical trial for clinical candidate OATD-01 in the countries of the European Union and Norway

9 February 2024

Molecure invites to the R&D Day – an online scientific and educational meeting on February 6, 2024

29 January 2024

Molecure’s success in development of the mRNA discovery platform

12 December 2023

Molecure Announces Third Quarter 2023 Financial Results and Pipeline Highlights

31 October 2023

Molecure Announces First Half 2023 Results – Significant Financial and Operating Momentum

29 September 2023

Invitation to investor meeting 3rd October 2023, 2:00 pm (CET)

20 September 2023

Events & Presentations

EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018

17 September 2018

ERS International Congress 2018 – Paris, France 15-19.09.2018

14 September 2018

54th International Conference on Medicinal Chemistry, Strasbourg, France – July 4-6, 2018.

17 July 2018

ATS 2018, 18 – 23 May, San Diego, USA

21 May 2018

ESMO Immuno Oncology Congress Geneva – December 7-10

1 December 2017

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 – 30, 2017

1 October 2017